Viewpoint Investment Partners’s Merck MRK Stock Holding History

Viewpoint Investment Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,500	Closed	-$263K	–	103
2025 Q4	$263K	Buy	+2,500	New	+$235K	0.13%	51

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Viewpoint Investment Partners's MRK Position: Q1 2026 in Review

Viewpoint Investment Partners sold out of Merck (MRK) in Q1 2026, closing a stake of 2,500 shares — an estimated $263K sold.

Viewpoint Investment Partners first reported a position in MRK in Q4 2025 and held it in 1 quarter. The position peaked at $263K in Q4 2025. 3,788 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Viewpoint Investment Partners reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
Viewpoint Investment Partners sold 2,500 Merck shares in Q1 2026, an estimated $263K.
Viewpoint Investment Partners first reported a position in Merck in Q4 2025 and held it in 1 quarter.
Viewpoint Investment Partners's Merck position peaked at $263K in Q4 2025.
3,788 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Viewpoint Investment Partners's 13F filing for Q1 2026, filed 23 Apr 2026.